Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Debt Ratio (2016 - 2022)

Historic Debt Ratio for Aptevo Therapeutics (APVO) over the last 8 years, with Q4 2022 value amounting to 0.1.

  • Aptevo Therapeutics' Debt Ratio fell 6281.27% to 0.1 in Q4 2022 from the same period last year, while for Dec 2022 it was 0.1, marking a year-over-year decrease of 6281.27%. This contributed to the annual value of 0.1 for FY2022, which is 6281.27% down from last year.
  • Latest data reveals that Aptevo Therapeutics reported Debt Ratio of 0.1 as of Q4 2022, which was down 6281.27% from 0.12 recorded in Q3 2022.
  • Aptevo Therapeutics' Debt Ratio's 5-year high stood at 0.67 during Q3 2020, with a 5-year trough of 0.1 in Q4 2022.
  • Over the past 5 years, Aptevo Therapeutics' median Debt Ratio value was 0.24 (recorded in 2019), while the average stood at 0.26.
  • Its Debt Ratio has fluctuated over the past 5 years, first soared by 10692.65% in 2020, then plummeted by 6478.32% in 2021.
  • Quarter analysis of 5 years shows Aptevo Therapeutics' Debt Ratio stood at 0.29 in 2018, then surged by 30.21% to 0.37 in 2019, then grew by 25.81% to 0.47 in 2020, then tumbled by 41.95% to 0.27 in 2021, then plummeted by 62.81% to 0.1 in 2022.
  • Its Debt Ratio was 0.1 in Q4 2022, compared to 0.12 in Q3 2022 and 0.11 in Q2 2022.